---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-115295"
form_type: "8-K"
ticker: "PACB"
cik: "0001299130"
company_name: "PACIFIC BIOSCIENCES OF CALIFORNIA, INC."
filed_at: "2024-11-07T23:59:59+00:00"
generated_at: "2026-05-30T03:20:55.314312+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# PacBio Q3 revenue falls 28% to $40M; CFO resigns; notes exchange with SoftBank

## Summary
- Revenue $40.0M (-28% YoY); instrument revenue $16.8M (down from $34.7M); 22 Revio systems shipped.
- Net loss $60.7M ($0.22/sh) vs $66.9M ($0.26) prior year; non-GAAP net loss $46.0M ($0.17).
- CFO Susan Kim resigns effective Dec 6; no severance; search for replacement underway.
- Announced $459M convertible note exchange (1.50% due 2028) with SoftBank, expected close Nov 21.
- Launched SPRQ chemistry increasing Revio throughput 33%; unveiled Vega benchtop sequencer at $169K.

## SEC filing metadata
- accession: 0001104659-24-115295
- form_type: 8-K
- ticker: PACB
- cik: 0001299130
- company_name: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- filed_at: 2024-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1299130/000110465924115295/0001104659-24-115295-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1299130/000110465924115295/tm2427787d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-115295
- JSON: https://secwatch.observer/filing/0001104659-24-115295.json
- Plain text: https://secwatch.observer/filing/0001104659-24-115295.txt

## Key facts
- Executive change
  Susan Kim resigned as Chief Financial Officer at PACIFIC BIOSCIENCES OF CALIFORNIA, INC..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On November 5, 2024, Susan Kim notified the Company that she is voluntarily resigning as Chief Financial Officer of the Company effective on December 6, 2024, to accept a position at another organization.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1299130/000110465924115295/0001104659-24-115295-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.